| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Biomarin Pharmaceutical Inc.'s insiders have reduced their positions by a net 17,557 shares worth roughly $1.2M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 214.6K | $11.95M | - | |
| CFO | 123.3K | $6.86M | - | |
| VP | 84.1K | $4.68M | - | |
| VP | 61.0K | $3.40M | - | |
| Dir | 49.4K | $2.75M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2017 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 5,000 | $92.68 | $463,400.00 | -2.4% | |
| Mar 10, 2017 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 11,000 | $90.59 | $996,530.00 | -5.1% | |
| Mar 7, 2017 | Jeffrey Robert Ajer58 | EVP, Chief Commercial Officer | Sell | 5,000 | $90.56 | $452,800.00 | -9.7% | |
| Mar 6, 2017 | Daniel K Spiegelman59 | EVP, Chief Financial Officer | Sell | 2,303 | $93.32 | $214,915.96 | -10.0% | |
| Mar 6, 2017 | George Eric Davis65 | EVP, General Counsel | Sell | 1,498 | $93.32 | $139,793.36 | -1.9% | |
| Mar 1, 2017 | V Bryan Lawlis53 | Director | Sale+OE | 7,500 | $95.00 | $712,500.00 | -35.1% | |
| Mar 1, 2017 | Daniel K Spiegelman59 | EVP, Chief Financial Officer | Sale+OE | 35,000 | $94.07 | $3,292,500.00 | -58.0% | |
| Feb 24, 2017 | Henry J Fuchs | President, Worldwide R& D | Sale+OE | 15,000 | $87.99 | $1,319,850.00 | -10.5% | |
| Jan 26, 2017 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 10,000 | $84.22 | $842,200.00 | -5.5% | |
| Jan 11, 2017 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 8,000 | $90.58 | $724,600.00 | -4.5% |